Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis
about
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosisBiomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.Macrophage subsets and microglia in multiple sclerosis.Frontline Science: CXCR7 mediates CD14(+)CD16(+) monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS.The prognostic significance of serum and cerebrospinal fluid MMP-9, CCL2 and sVCAM-1 in leukemia CNS metastasis.Increased CXCL10 expression in MS MSCs and monocytes is unaffected by AHSCT.Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin.Anti-LINGO-1 has no detectable immunomodulatory effects in preclinical and phase 1 studies.Promise, Progress, and Pitfalls in the Search for Central Nervous System Biomarkers in Neuroimmunological Diseases: A Role for Cerebrospinal Fluid Immunophenotyping.Defining active progressive multiple sclerosis.Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics.
P2860
Q26770818-890C5E31-B69D-4308-9EA0-B6BC3800A2DDQ35364112-9E148AD7-5322-4B58-B9A7-02EF00A60E18Q38222226-427B3470-E933-4746-B408-18AFBA83BF46Q38654347-C48C69B9-13F5-4851-B8DA-24EF45E6F807Q41513151-B640D99B-524E-4821-A688-59C986F00EB4Q42708031-11E39327-BA53-4458-8D74-FCA55770B121Q44587763-88F3AC5D-DC28-4F0E-940B-30411D2CB8D8Q47094091-5E630CC7-28D9-40B1-9F5E-08015368CDA9Q47657261-C1B6478A-D577-48A8-9F9B-468EAFFA83C6Q47918387-8921D0E0-9489-4902-8EA4-1DF1EA9B65B7Q55052878-DA4125F8-3566-4FCE-AD74-CB3102583835Q55379242-60E558C9-0E34-473A-BF46-921EF7EDAA39
P2860
Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Feasibility of the use of comb ...... and CSF in multiple sclerosis
@ast
Feasibility of the use of comb ...... and CSF in multiple sclerosis
@en
Feasibility of the use of comb ...... and CSF in multiple sclerosis
@nl
type
label
Feasibility of the use of comb ...... and CSF in multiple sclerosis
@ast
Feasibility of the use of comb ...... and CSF in multiple sclerosis
@en
Feasibility of the use of comb ...... and CSF in multiple sclerosis
@nl
prefLabel
Feasibility of the use of comb ...... and CSF in multiple sclerosis
@ast
Feasibility of the use of comb ...... and CSF in multiple sclerosis
@en
Feasibility of the use of comb ...... and CSF in multiple sclerosis
@nl
P2093
P2860
P1433
P1476
Feasibility of the use of comb ...... and CSF in multiple sclerosis
@en
P2093
Ann Ranger
Diego Cadavid
Jaya Goyal
Jeffrey L Browning
Julie Czerkowicz
Keith R Edwards
Susan Goelz
Tatiana Plavina
P2860
P304
P356
10.1371/JOURNAL.PONE.0081007
P407
P577
2013-01-01T00:00:00Z